A2V (p.Ala2Val) variant of CDK9 (Cyclin-dependent kinase 9)
A2V (p.Ala2Val) in CDK9 (Cyclin-dependent kinase 9) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data, published literature, and structural context.
A2V (p.Ala2Val) variant details
- p.Ala2Val
- gnomAD 9-127785811-C-T
- Missense
- Variant Prioritization Score for Impact Estimate 0.37
- CADD 16.10
- SIFT 0.00
- Population evidence available
- Structural context available
- Literature evidence available